DividendInvestor.com
First In Dividend Data Worldwide®
Press Release
Range Cancer Therapeutics ETF/ETF Series Solutions (NASDAQ:CNCR),
DIVIDEND STOCK ANNOUNCEMENT: ETF Series Solutions (NASDAQ: CNCR) today declared a dividend of $0.1055 per share
Dec 28, 2015
For Immediate ReleaseETF Series Solutions (NASDAQ: CNCR) today declared a dividend of $0.1055 per share payable on January 04, 2016 to shareholders of record as of December 31, 2015. Dividend amount recorded is an increase of $0.1055 from last dividend Paid
Range Cancer Therapeutics ETF/ETF Series Solutions (NASDAQ:CNCR) has paid dividends since 2016 and has a current dividend yield of 0.0000000000%
Range Cancer Therapeutics ETF/ETF Series Solutions current dividend information as per the date of this press release is:
Dividend Declaration Date: Dec-28-2015
Dividend Ex Date: Dec-29-2021
Dividend Record Date: Dec-30-2021
Dividend Payment Date: Dec-31-2021
Dividend Amount: 18533.400
Dividend Ex Date: Dec-29-2021
Dividend Record Date: Dec-30-2021
Dividend Payment Date: Dec-31-2021
Dividend Amount: 18533.400
CNCR LINKS
CNCR Dividend History Detail
CNCR Projected 10 Year Dividend Yield
CNCR Dividend News
CNCR Competitors News
DividendInvestor.com
DividendInvestor.com is a leading worldwide independent provider of dividend information and data for investment professionals. Our mission is to be the First In Dividend Data Worldwide® by designing and developing essential tools and systems for the investment community with the highest level of accuracy and integrity.
Contact:
info@DividendInvestor.com
